CClinicalTrials.gg
RecruitingNCT06929598ShiQoLUpdated Sep 29, 2026

Shiatsu for Chronic Non-Inflammatory Pain in Children and Adolescents

An interventional study of Shiatsu Therapy in Chronic Pain, Chronic Pain Syndrome and Chronic Pain and Comorbid Emotional Problems, sponsored by Tel Aviv University. Recruiting at 2 sites in Israel. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Tel Aviv University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
10 Years to 18 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if adding Shiatsu therapy to standard treatment can improve quality of life in children and adolescents with chronic pain that is not caused by inflammation. The main question it aims to answer is: Does Shiatsu therapy help improve the quality of life in children with long-lasting pain?

All participants will continue their regular treatment and will also:

  • Receive a 30-minute Shiatsu session once a week for six weeks
  • Complete questionnaires about their quality of life and family impact before, during, and after the treatment period

The study includes about 40 participants between the ages of 10 and 18, who are already being followed at the pediatric pain and rheumatology clinics at Tel Aviv Sourasky Medical Center.

02

Conditions studied

  • Chronic Pain
  • Chronic Pain Syndrome
  • Chronic Pain and Comorbid Emotional Problems
  • Chronic Pain, Psychogenic
  • Chronic Pain, Widespread
  • Fibromyalgia
  • Fibromyalgia Syndrome
  • Functional Pain

Keywords

  • Shiatsu
  • Complementary and Integrative Medicine
  • Pediatric Chronic Pain
  • Non-inflammatory Pain
  • Quality of Life
  • PedsQL
  • Adolescent Pain
  • Manual Therapy
  • Mind-Body Therapy
  • Pediatric Rheumatology
  • Integrative Medicine
  • Functional Pain
  • Pain Management
03

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children and adolescents aged 10-18 years
  • Diagnosed with non-inflammatory chronic pain syndromes
  • Actively followed by the Pediatric Rheumatology and/or Pediatric Pain Clinics at Tel Aviv Sourasky Medical Center (at least twice a year)
  • Informed consent signed by at least one legal guardian (or both guardians in cases of separated parents)
  • If participant is 16 years or older, they must also sign the informed consent

Exclusion criteria

Exclusion Criteria:

  • Informed consent cannot be obtained from the participant or their legal guardians
  • Legal guardians unable to provide informed consent
  • Patients with severe conditions (e.g., bone metastasis)
  • Patients unable to participate in Shiatsu therapy sessions
  • Participation in Shiatsu therapy within 6 months prior to study enrollment
  • Participant or legal guardian refuses participation
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Shiatsu Therapy Group

    Participants will receive 30-minute Shiatsu therapy sessions once a week for 6 weeks, in addition to their usual pain management. The goal is to assess whether Shiatsu improves quality of life in children and adolescents with non-inflammatory chronic pain.

    Behavioral: Shiatsu Therapy

Interventions

  • BehavioralShiatsu Therapy

    Participants will receive one 30-minute session of Shiatsu therapy per week for 6 weeks. Therapy will be provided by trained Shiatsu practitioners under a standardized protocol developed for this study.

05

What researchers measure

Primary outcomes

  1. Change in Pediatric Quality of Life Inventory Version 4.0 (PedsQL 4.0) Generic Core Scale Total Score

    The PedsQL 4.0 Generic Core Scale is a validated questionnaire that measures health-related quality of life in children and adolescents. Participants will complete the age-appropriate version of the PedsQL. It includes 23 items across four subscales: physical, emotional, social, and school functioning. Responses are reverse-scored and transformed to a 0-100 scale. Higher scores indicate better quality of life. The change in total score from baseline to follow-up time points will be assessed.

    Time frame: Baseline (Day 0), Week 3 (after the 3rd Shiatsu session), Week 6 (after the 6th Shiatsu session, end of intervention), and Week 18 (3 months post-intervention)

Secondary outcomes

  1. Change in Pediatric Quality of Life Inventory Family Impact Module (PedsQL FIM) Total Score

    The Pediatric Quality of Life Inventory Family Impact Module (PedsQL FIM) is a validated caregiver-reported questionnaire that assesses the impact of a child's health condition on family functioning. It includes 36 items covering physical, emotional, social, and cognitive functioning, communication, worry, daily activities, and family relationships. Responses are reverse-scored and transformed to a 0-100 scale. Higher scores indicate better family functioning and less caregiver burden. The change in total score from baseline to follow-up time points will be assessed.

    Time frame: Baseline (Day 0), Week 3 (after the 3rd Shiatsu session), Week 6 (after the 6th Shiatsu session, end of intervention), and Week 18 (3 months post-intervention)

  2. Change in Pain Intensity (Numerical Rating Scale, NRS)

    Pain intensity will be self-reported using the Numerical Rating Scale (NRS), a validated 11-point scale ranging from 0 to 10, where 0 means "no pain" and 10 means "worst possible pain." Participants will rate their pain at each time point. The change in score from baseline to follow-up time points will be assessed.

    Time frame: Baseline (Day 0), Week 3 (after the 3rd Shiatsu session), Week 6 (after the 6th Shiatsu session, end of intervention), and Week 18 (3 months post-intervention)

06

Study locations

1 of 2 sites recruiting
  • Tel Aviv Univrsity
    Tel Aviv, Tel Aviv, Israel
    Not yet recruiting
  • Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center
    Tel Aviv, 64239-06, Israel
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided — The research team has not yet finalized a plan for sharing individual participant data (IPD). Data sharing options will be considered in accordance with institutional board review, policies, ethical guidelines in our institution, ethical guidelines for pediatric research, and data privacy regulations.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06929598
Lead sponsor
Tel Aviv University
Collaborators
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, Dana-Dwek Children's Hospital
Responsible party
Eyal Cohen-Sela (Medical Doctor, Tel Aviv University) — Principal investigator
First posted
Apr 16, 2025
Start date
May 1, 2025
Primary completion
Sep 30, 2028 (estimated)
Completion
Sep 30, 2028 (estimated)
Last update
Sep 29, 2026

Study contacts

Eyal Cohen-Sela, MD
Contact
cohensela@mail.tau.ac.il
+972-3-6974247
Merav Heshin-Bekenstein, MD
Contact
prheum@tlvmc.gov.il
+972-3-6974247
Merav Heshin-Bekenstein, MD
principal investigator · Dana Dwek Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion